Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Rev. Soc. obstet. ginecol. B.Aires ; 74(916): 263-72, nov. 1995. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-177407

RESUMO

El trasplante renal se acompaña de una importante mejoría de la función reproductiva de las pacientes con enfermedad renal terminal. Se analizaron retrospectivamente los datos de 11 embarazos, correspondientes a 9 pacientes trasplantadas renales que presentaron: 8 recién nacidos vivos: 5 de término ò 37 semanas y 3 pretérmino (37 por ciento); 1 huevo muerto y 2 abortos provocados. La edad gestacional media fue de 36,5 semanas y el peso medio fue de 2.225 gr. La edad media al momento del embarazo fue de 26,4 ñ 5,2 años y el lapso medio desde el trasplante al embarazo fue de 38 meses (rango 6-72 meses). Todas continuaron la inmunosupresión durante la gestación. Siete embarazos (63 por ciento) cursaron con complicaciones médicas. No se detectaron malformaciones congénitas en ninguno de los recién nacidos y tampoco ninguna de las pacientes presentó rechazo agudo del riñón transplantado. Concluimos que las pacientes con trasplante renal pueden tener embarazos exitosos pero no exentos de riesgo para la madre y para el feto


Assuntos
Humanos , Feminino , Gravidez , Cuidado Pré-Concepcional/normas , Transplante de Rim , Gravidez , Complicações na Gravidez , Resultado da Gravidez , Gravidez de Alto Risco , Cuidado Pré-Natal , Azatioprina/efeitos adversos , Ciclosporina/administração & dosagem , Rejeição de Enxerto
2.
Rev. Soc. obstet. ginecol. B.Aires ; 74(916): 263-72, nov. 1995. ilus, tab
Artigo em Espanhol | BINACIS | ID: bin-21842

RESUMO

El trasplante renal se acompaña de una importante mejoría de la función reproductiva de las pacientes con enfermedad renal terminal. Se analizaron retrospectivamente los datos de 11 embarazos, correspondientes a 9 pacientes trasplantadas renales que presentaron: 8 recién nacidos vivos: 5 de término ò 37 semanas y 3 pretérmino (37 por ciento); 1 huevo muerto y 2 abortos provocados. La edad gestacional media fue de 36,5 semanas y el peso medio fue de 2.225 gr. La edad media al momento del embarazo fue de 26,4 ñ 5,2 años y el lapso medio desde el trasplante al embarazo fue de 38 meses (rango 6-72 meses). Todas continuaron la inmunosupresión durante la gestación. Siete embarazos (63 por ciento) cursaron con complicaciones médicas. No se detectaron malformaciones congénitas en ninguno de los recién nacidos y tampoco ninguna de las pacientes presentó rechazo agudo del riñón transplantado. Concluimos que las pacientes con trasplante renal pueden tener embarazos exitosos pero no exentos de riesgo para la madre y para el feto


Assuntos
Humanos , Feminino , Gravidez , Transplante de Rim , Gravidez de Alto Risco , Gravidez , Resultado da Gravidez , Cuidado Pré-Concepcional/normas , Cuidado Pré-Natal , Complicações na Gravidez , Azatioprina/efeitos adversos , Rejeição de Enxerto , Ciclosporina/administração & dosagem
7.
Am J Med ; 85(3): 349-52, 1988 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3414730

RESUMO

PURPOSE: Previous studies have compared the relationship between directly measured values for cardiac output, systemic oxygen consumption (VO2), and arteriovenous oxygen difference (D(A-v)O2) with those calculated by the Fick principle. However, the validity of Fick's principle in critically ill patients undergoing physiologic changes and pharmacologic interventions is unknown. The purpose of our study was to compare directly measured values for hemodynamic and oxymetric variables with those calculated by the Fick equation in patients with acute myocardial infarction, at baseline and after the hemodynamic changes produced by pharmacologic interventions. PATIENTS AND METHODS: Cardiac output, (VO2), and (D(A-v)O2) were measured in 33 patients with acute myocardial infarction, at baseline (50 +/- 30 hours after the onset of symptoms) and after pharmacologic intervention to relieve pulmonary congestion. These values were then compared with indirect values derived from the Fick equation. RESULTS: High and significant correlations were found between thermodilution and Fick-derived cardiac output at baseline (r = 0.91, p less than 0.001) and post-intervention (r = 0.92, p less than 0.001). Similarly, VO2 values measured by expired gas analysis showed a significant correlation with VO2 calculated by the Fick principle, at baseline (r = 0.85, p less than 0.001) and post-intervention (r = 0.84, p less than 0.001). Lastly, when D(A-v)O2 of arterial and mixed venous samples was measured by spectrophotometry and compared with calculated values, there was a significant correlation at baseline (r = 0.85, p less than 0.001) and after intervention (r = 0.85, p less than 0.001). Analysis of variance revealed no difference between measured and calculated values for the three variables under those two conditions. CONCLUSION: In patients with acute myocardial infarction, cardiac output, VO2, and D(A-v)O2 indirectly calculated by the Fick principle are equivalent to directly measured values, despite the various degrees of hemodynamic dysfunction and the currently used therapeutic interventions.


Assuntos
Débito Cardíaco , Infarto do Miocárdio/fisiopatologia , Oximetria/métodos , Consumo de Oxigênio , Oxigênio/sangue , Idoso , Feminino , Humanos , Masculino , Matemática , Pessoa de Meia-Idade , Termodiluição
9.
Chemotherapy ; 33(5): 316-21, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-3665629

RESUMO

In order to avoid gentamicin toxicity trough serum concentrations when drug monitoring is not available, a correction factor for serum creatinine was calculated and evaluated. In a first group of 35 patients under aminoglycoside treatment with variable serum creatinine (SCr) values, the regression plot of SCr concentrations versus half-life (T1/2) values was established: log T1/2 = log 2.28 + 1.45 log SCr, r = 0.90, p less than 0.01. A second group of 18 patients was treated with doses of 1.0 mg/kg of gentamicin. Dose intervals equivalent to 3 T1/2 were daily adjusted. The T1/2 was calculated from SCr according to the relationship established for the patients of the first group. All the patients studied maintained trough levels within the therapeutic range.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Creatinina/sangue , Gentamicinas/administração & dosagem , Adulto , Idoso , Infecções Bacterianas/sangue , Relação Dose-Resposta a Droga , Esquema de Medicação , Gentamicinas/farmacocinética , Taxa de Filtração Glomerular , Meia-Vida , Humanos , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA